M. Divoux

In Multiple Myeloma, High-Risk Secondary Genetic Events Observed at Relapse Are Present From Diagnosis in Tiny, Undetectable Subclonal Populations

M. Mohty, M. Samur, H. Avet-Loiseau, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Heterogeneity in long-term outcomes for patients with Revised International Staging System stage II, newly diagnosed multiple myeloma

O. Decaux, M. Mohty, P. Moreau, 2022, Haematologica.

Correlation between DNA Methylation and Cell Proliferation Identifies New Candidate Predictive Markers in Meningioma

C. Godfraind, Sébastien Hergalant, S. Lacomme, 2022, Cancers.

Idelalisib in a patient with refractory Waldenström’s macroglobulinemia complicated by anuric renal failure: a case report

J. Broséus, P. Feugier, M. Muller, 2018, Journal of Medical Case Reports.

Primary Plasma Cell Leukemia displaying t(11;14) have specific genomic, transcriptional and clinical feature.

M. Mohty, H. Avet-Loiseau, M. Macro, 2022, Blood.

Biallelic deletion of 1p32 defines ultra-high-risk myeloma, but monoallelic del(1p32) remains a strong prognostic factor.

M. Mohty, H. Avet-Loiseau, M. Macro, 2022, Blood.

Heterogeneity in long-term outcomes for patients with Revised International Staging System stage II, newly diagnosed multiple myeloma

O. Decaux, M. Mohty, P. Moreau, 2022, Haematologica.

Clinical and Biological Characteristics and Outcomes of Richter Transformation : A French Multicenter Study from the Filo Group

P. Feugier, M. Béné, H. Auge, 2019, Blood.